74 related articles for article (PubMed ID: 21460905)
21. Potential ability of hematoporphyrin to enhance an optical coherence tomographic image of gastric cancer in vivo in mice.
Xiong H; Zeng C; Guo Z; Zhong H; Wang R; Liu S; He Y
Phys Med Biol; 2008 Dec; 53(23):6767-75. PubMed ID: 18997266
[TBL] [Abstract][Full Text] [Related]
22. Multimodality imaging of IL-18--binding protein-Fc therapy of experimental lung metastasis.
Cao Q; Cai W; Niu G; He L; Chen X
Clin Cancer Res; 2008 Oct; 14(19):6137-45. PubMed ID: 18829492
[TBL] [Abstract][Full Text] [Related]
23. Use of an image restoration process to improve spatial resolution in bioluminescence imaging.
Pesnel S; Akkoul S; Ledée R; Leconge R; Pillon A; Kruczynski A; Harba R; Lerondel S; Le Pape A
Mol Imaging; 2011 Dec; 10(6):446-52. PubMed ID: 22201535
[TBL] [Abstract][Full Text] [Related]
24. Total variation regularization for bioluminescence tomography with the split Bregman method.
Feng J; Qin C; Jia K; Zhu S; Liu K; Han D; Yang X; Gao Q; Tian J
Appl Opt; 2012 Jul; 51(19):4501-12. PubMed ID: 22772124
[TBL] [Abstract][Full Text] [Related]
25. An immunocompetent murine model of metastatic mammary cancer accessible to bioluminescence imaging.
Shibata MA; Shibata E; Morimoto J; Eid NA; Tanaka Y; Watanabe M; Otsuki Y
Anticancer Res; 2009 Nov; 29(11):4389-95. PubMed ID: 20032383
[TBL] [Abstract][Full Text] [Related]
26. Adaptive improved element free Galerkin method for quasi- or multi-spectral bioluminescence tomography.
Qin C; Yang X; Feng J; Liu K; Liu J; Yan G; Zhu S; Xu M; Tian J
Opt Express; 2009 Nov; 17(24):21925-34. PubMed ID: 19997437
[TBL] [Abstract][Full Text] [Related]
27. Spectrally resolved bioluminescence tomography with adaptive finite element analysis: methodology and simulation.
Lv Y; Tian J; Cong W; Wang G; Yang W; Qin C; Xu M
Phys Med Biol; 2007 Aug; 52(15):4497-512. PubMed ID: 17634646
[TBL] [Abstract][Full Text] [Related]
28. Second-generation triple reporter for bioluminescence, micro-positron emission tomography, and fluorescence imaging.
Kesarwala AH; Prior JL; Sun J; Harpstrite SE; Sharma V; Piwnica-Worms D
Mol Imaging; 2006; 5(4):465-74. PubMed ID: 17150159
[TBL] [Abstract][Full Text] [Related]
29. Noninvasive visualization of retinoblastoma growth and metastasis via bioluminescence imaging.
Ji X; Cheng L; Wei F; Li H; Wang M; Tian Y; Chen X; Wang Y; Wolf F; Li C; Huang Q
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5544-51. PubMed ID: 19608529
[TBL] [Abstract][Full Text] [Related]
30. The intraportal injection model for liver metastasis: advantages of associated bioluminescence to assess tumor growth and influences on tumor uptake of radiolabeled anti-carcinoembryonic antigen antibody.
Frampas E; Maurel C; Thedrez P; Remaud-Le Saëc P; Faivre-Chauvet A; Barbet J
Nucl Med Commun; 2011 Feb; 32(2):147-54. PubMed ID: 21116205
[TBL] [Abstract][Full Text] [Related]
31. Multimodal imaging of neural progenitor cell fate in rodents.
Waerzeggers Y; Klein M; Miletic H; Himmelreich U; Li H; Monfared P; Herrlinger U; Hoehn M; Coenen HH; Weller M; Winkeler A; Jacobs AH
Mol Imaging; 2008; 7(2):77-91. PubMed ID: 18706290
[TBL] [Abstract][Full Text] [Related]
32. A fast bioluminescent source localization method based on generalized graph cuts with mouse model validations.
Liu K; Tian J; Lu Y; Qin C; Yang X; Zhu S; Zhang X
Opt Express; 2010 Feb; 18(4):3732-45. PubMed ID: 20389383
[TBL] [Abstract][Full Text] [Related]
33. Bioluminescence as gold standard for validation of optical imaging modalities in peritoneal carcinomatosis animal models.
Harlaar NJ; Hesselink JW; de Jong JS; van Dam GM
Eur Surg Res; 2010; 45(3-4):308-13. PubMed ID: 21042026
[TBL] [Abstract][Full Text] [Related]
34. In vivo bioluminescence visualization of antitumor effects by human MUC1 vaccination.
Jeon YH; Choi Y; Kim HJ; Kang JH; Kim CW; Jeong JM; Lee DS; Chung JK
Mol Imaging; 2007; 6(5):297-303. PubMed ID: 18092514
[TBL] [Abstract][Full Text] [Related]
35. Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer.
Scatena CD; Hepner MA; Oei YA; Dusich JM; Yu SF; Purchio T; Contag PR; Jenkins DE
Prostate; 2004 May; 59(3):292-303. PubMed ID: 15042605
[TBL] [Abstract][Full Text] [Related]
36. Noninvasive bioluminescence imaging of normal and spontaneously transformed prostate tissue in mice.
Lyons SK; Lim E; Clermont AO; Dusich J; Zhu L; Campbell KD; Coffee RJ; Grass DS; Hunter J; Purchio T; Jenkins D
Cancer Res; 2006 May; 66(9):4701-7. PubMed ID: 16651422
[TBL] [Abstract][Full Text] [Related]
37. Bifunctional antibody-Renilla luciferase fusion protein for in vivo optical detection of tumors.
Venisnik KM; Olafsen T; Loening AM; Iyer M; Gambhir SS; Wu AM
Protein Eng Des Sel; 2006 Oct; 19(10):453-60. PubMed ID: 16882674
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of tumor growth in xenografted nude mice with adenovirus-mediated endostatin gene comparison with recombinant endostatin protein.
Liang ZH; Wu PH; Li L; Xue G; Zeng YX; Huang WL
Chin Med J (Engl); 2004 Dec; 117(12):1809-14. PubMed ID: 15603709
[TBL] [Abstract][Full Text] [Related]
39. [Synergistic effect of bromocriptine combining tumor necrosis factor-alpha on reversing multidrug resistance in a nude mouse model of liver neoplasm].
Ding L; Chen XP; Zhang ZW; Wang H; Cao B; Wang ZH; Li CL
Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(19):1248-53. PubMed ID: 16271222
[TBL] [Abstract][Full Text] [Related]
40. Integrated imaging approach to tumor model mice using bioluminescence imaging and magnetic resonance imaging.
Inoue Y; Masutani Y; Kiryu S; Haishi T; Watanabe M; Tojo A; Ohtomo K
Mol Imaging; 2010 Jun; 9(3):163-72. PubMed ID: 20487682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
